21 results on '"Shao, Yu-Yun"'
Search Results
2. IMbrave150: Exploratory analysis to examine the association between bevacizumab (bev) ever being skipped and bev never being skipped in patients with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab (atezo) + bev in a global phase 3 study.
3. Sidedness and addition of chemotherapy associated with treatment outcomes of regorafenib for metastatic colorectal cancer (mCRC).
4. Real-world registry of patients with unresectable hepatocellular carcinoma: The OREIOS study.
5. Cyclin dependent kinase 9 inhibition as a potential treatment for hepatocellular carcinoma.
6. Total skeletal, psoas, and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma.
7. Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict efficacy of axitinib for treatment of advanced hepatocellular carcinoma (HCC).
8. Comparison of irinotecan and oxaliplatin as adjuvant chemotherapy for patients with resectable synchronous colon cancer plus liver-confined metastases: A retrospective nationwide database study.
9. Effect of national policy changes on hospice utilization and the invasiveness of end-of-life care in cancer patients.
10. PVR expression in tumor microenvironment of advanced hepatocellular carcinoma.
11. The use of opioids not recommended in guidelines in Taiwan cancer patients.
12. Tumor c-Met expression and prognosis of advanced hepatocellular carcinoma patients treated with sorafenib.
13. The impact of diabetes mellitus on early cervical cancer in Αsia: A population-based cohort study.
14. Phase Ib study of RO5137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170).
15. Risk of second primary malignancies in young patients with colorectal cancer.
16. Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC.
17. Clinical features of long-term survivors (LTS) of advanced hepatocellular carcinoma undergoing molecular targeted therapy (MTT).
18. Regular statin users and colorectal cancer (CRC) prognosis.
19. Survival of patients receiving radiofrequency ablation or ethanol injection for early-stage hepatocellular carcinoma.
20. Unique histopathologic features of brain metastases from hepatocellular carcinoma.
21. Association of diabetes mellitus with increased mortality in patients receiving curative surgery for colon cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.